NCT02945904View on ClinicalTrials.gov

IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Primary AldosteronismHyperaldosteronism
Interventions
PROCEDURE

adrenalectomy

Unilateral adrenalectomy for Conn's adenoma

Trial Locations (1)

EC1 6BQ

Queen Mary University of London, City of London

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

WBIC), Cambridge. University of Cambridge Addenbrookes Hospital, Cambridge CB2 2QQ

UNKNOWN

collaborator

Robertson Centre for Biostatistics University of Glasgow Glasgow G12 8QQ

UNKNOWN

collaborator

Barts and the London School of Medicine and Dentistry W Smithfield London - City of London EC1A 7BE

UNKNOWN

lead

Queen Mary University of London

OTHER

NCT02945904 - IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism | Biotech Hunter | Biotech Hunter